Life sciences & healthcare legal cluster: Hub · Dawn raid · VBP · Hospital AR · Exclusive agency · HGR · Trial injury · CRO/CDMO · Device liability · Labeling · SaMD · Patent linkage · License · FDA WL · MDR/IVDR · Internet hospital · Trade secrets · Pharma ads · Device distribution · Sources · Checklist
Why in-house teams search this
- Generic filings with non-infringement / invalidity-style declarations against listed patents.
- Originator decisions: sue, seek administrative avenues, settle, or authorise.
- Launch-at-risk calculus and preliminary measure strategy.
- Coordination with global patent families and foreign litigations.
Process posture (orientation)
Expect a structured interplay among patent information registration, applicant declarations, notice to rights holders, and civil litigation and/or administrative adjudication routes under the linkage framework. Deadlines are unforgiving—build a watch service on your listed patents and competitive filings, not ad-hoc Google alerts.
Generic challenge themes
Challengers attack validity (including data sufficiency fights) or design around claims. Post-filed experimental data practice in invalidation can be decisive—align patent and regulatory data strategies early. FTO for the commercial process and formulation sits beside linkage litigation, not after it.
Originator defence themes
- Portfolio hygiene: listable patents that actually block commercially relevant products.
- Evidence packs for infringement (samples, process inference, expert experiments).
- Settlement structures that survive anti-monopoly and tender optics.
- Parallel trade-secret protection when reverse-engineering disputes appear.
PTE / exclusivity-adjacent timing
Patent term extension and regulatory exclusivity concepts affect how long a franchise is worth defending. Model dates explicitly; do not assume US PTE arithmetic applies unchanged. Tax and deal teams should see the same timeline as litigators when valuing License-out remaining term (licensing guide).
Related IP spines on this site
General patent litigation and trade-secret materials remain useful for evidence and damages methodology, but linkage is a specialised procedural track—use this page as the healthcare door, then deep-dive statutes with patent counsel.
Related
FAQ · 高频检索问题
Chinese long-tail intents mapped to this guide (orientation only).
中国药品专利链接诉讼流程是什么？
仿制药 4 类声明如何应对？
专利期限补偿 / 数据独占如何影响策略？
Need sector counsel?
Map your issue to a specialty desk: Life sciences & healthcare · Devices & IVD · Clinical & health data · Product liability · Industry hub.
Find counsel
